Tower Research Capital LLC (Trc) Entera Bio Ltd. Transaction History

Tower Research Capital LLC (Trc)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.43 - $6.29 $39,905 - $56,660	-9,008 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.92 - $6.5 $37,933 - $84,441	-12,991 Reduced 59.05%	9,008 $54,000
Q1 2021 May 17, 2021	BUY	$1.16 - $6.9 $25,518 - $151,793	21,999 New	21,999 $84,000
Q3 2019 Nov 05, 2019	SELL	$2.11 - $3.75 $1,818 - $3,232	-862 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$2.92 - $4.4 $292 - $440	-100 Reduced 10.4%	862 $3,000
Q1 2019 May 14, 2019	BUY	$3.01 - $4.84 $2,889 - $4,646	960 Added 48000.0%	962 $4,000
Q4 2018 Feb 14, 2019	BUY	$3.0 - $5.85 $6 - $11	2 New	2 $0

5.34M

2.6K

100

Ticker ENTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,809,900
Market Cap $65.1M
Description
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.